These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 20963561)

  • 1. Age, body mass index, and serum level of DHEA-S can predict glucocorticoid receptor function in women with polycystic ovary syndrome.
    Macut D; Vojnović Milutinović D; Božić I; Matić G; Brkljačić J; Panidis D; Petakov M; Spanos N; Bjekić J; Stanojlović O; Petrović Milinković A; Radojičić Z; Damjanović S
    Endocrine; 2010 Feb; 37(1):129-34. PubMed ID: 20963561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of combined oral contraceptives containing drospirenone on hypothalamic-pituitary-adrenocortical axis activity and glucocorticoid receptor expression and function in women with polycystic ovary syndrome.
    Macut D; Božić Antić I; Nestorov J; Topalović V; Bjekić Macut J; Panidis D; Kastratović Kotlica B; Papadakis E; Matić G; Vojnović Milutinović D
    Hormones (Athens); 2015; 14(1):109-17. PubMed ID: 25402380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypothalamic-pituitary-adrenocortical axis hypersensitivity and glucocorticoid receptor expression and function in women with polycystic ovary syndrome.
    Milutinović DV; Macut D; Božić I; Nestorov J; Damjanović S; Matić G
    Exp Clin Endocrinol Diabetes; 2011 Nov; 119(10):636-43. PubMed ID: 22068557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucocorticoid receptors on mononuclear leukocytes in polycystic ovary syndrome.
    Güven M; Açbay O; Sultuybek G
    Int J Gynaecol Obstet; 1998 Oct; 63(1):33-7. PubMed ID: 9849709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolactin is associated with metabolic risk and cortisol in 1007 women with polycystic ovary syndrome.
    Glintborg D; Altinok M; Mumm H; Buch K; Ravn P; Andersen M
    Hum Reprod; 2014 Aug; 29(8):1773-9. PubMed ID: 24903198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ovulation after glucocorticoid suppression of adrenal androgens in the polycystic ovary syndrome is not predicted by the basal dehydroepiandrosterone sulfate level.
    Azziz R; Black VY; Knochenhauer ES; Hines GA; Boots LR
    J Clin Endocrinol Metab; 1999 Mar; 84(3):946-50. PubMed ID: 10084576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the efficacy of different androgens measured by LC-MS/MS in representing hyperandrogenemia and an evaluation of adrenal-origin androgens with a dexamethasone suppression test in patients with PCOS.
    Chen F; Chen M; Zhang W; Yin H; Chen G; Huang Q; Yang X; Chen L; Lin C; Yin G
    J Ovarian Res; 2021 Feb; 14(1):32. PubMed ID: 33583431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adrenal androgen production capacity remains high up to menopause in women with polycystic ovary syndrome.
    Puurunen J; Piltonen T; Jaakkola P; Ruokonen A; Morin-Papunen L; Tapanainen JS
    J Clin Endocrinol Metab; 2009 Jun; 94(6):1973-8. PubMed ID: 19318449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of adrenocortical steroidogenesis in women with post-adolescent severe acne and polycystic ovary syndrome.
    Cinar N; Cetinozman F; Aksoy DY; Elcin G; Yildiz BO
    J Eur Acad Dermatol Venereol; 2015 May; 29(5):875-80. PubMed ID: 25176476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dehydroepiandrosterone sulfate/free androgen index ratio predicts a favorable metabolic profile in patients with polycystic ovary syndrome.
    Nadir A; Temizkan S; Ozderya A; Temizkan O; Orbay E; Aydin K
    Gynecol Endocrinol; 2019 Feb; 35(2):128-132. PubMed ID: 30324855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heterogeneity of Endocrinologic and Metabolic Parameters in Reproductive Age Polycystic Ovary Syndrome (PCOS) Women Concerning the Severity of Hyperandrogenemia-A New Insight on Syndrome Pathogenesis.
    Ozegowska K; Korman M; Szmyt A; Pawelczyk L
    Int J Environ Res Public Health; 2020 Dec; 17(24):. PubMed ID: 33322590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dyslipidaemia in polycystic ovarian syndrome: different groups, different aetiologies?
    Meirow D; Raz I; Yossepowitch O; Brzezinski A; Rosler A; Schenker JG; Berry EM
    Hum Reprod; 1996 Sep; 11(9):1848-53. PubMed ID: 8921052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased ligand affinity rather than glucocorticoid receptor down-regulation in patients with endogenous Cushing's syndrome.
    Huizenga NA; De Herder WW; Koper JW; de Lange P; v D Lely AJ; Brinkmann AO; de Jong FH; Lamberts SW
    Eur J Endocrinol; 2000 May; 142(5):472-6. PubMed ID: 10802524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Body composition, fat distribution and metabolic characteristics in lean and obese women with polycystic ovary syndrome.
    Faloia E; Canibus P; Gatti C; Frezza F; Santangelo M; Garrapa GG; Boscaro M
    J Endocrinol Invest; 2004 May; 27(5):424-9. PubMed ID: 15279073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beyond adrenal and ovarian androgen generation: Increased peripheral 5 alpha-reductase activity in women with polycystic ovary syndrome.
    Fassnacht M; Schlenz N; Schneider SB; Wudy SA; Allolio B; Arlt W
    J Clin Endocrinol Metab; 2003 Jun; 88(6):2760-6. PubMed ID: 12788885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin-like factor 3 -- a new hormone related to polycystic ovary syndrome?
    Szydlarska D; Grzesiuk W; Trybuch A; Kondracka A; Kowalik I; Bar-Andziak E
    Endokrynol Pol; 2012; 63(5):356-61. PubMed ID: 23115068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stability of adrenocortical steroidogenesis over time in healthy women and women with polycystic ovary syndrome.
    Yildiz BO; Woods KS; Stanczyk F; Bartolucci A; Azziz R
    J Clin Endocrinol Metab; 2004 Nov; 89(11):5558-62. PubMed ID: 15531511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 24-hour serum cortisol profiles in women with polycystic ovary syndrome.
    Prelević GM; Würzburger MI; Balint-Perić L
    Gynecol Endocrinol; 1993 Sep; 7(3):179-84. PubMed ID: 8291455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metastin levels in relation with hormonal and metabolic profile in patients with polycystic ovary syndrome.
    Yilmaz SA; Kerimoglu OS; Pekin AT; Incesu F; Dogan NU; Celik C; Unlu A
    Eur J Obstet Gynecol Reprod Biol; 2014 Sep; 180():56-60. PubMed ID: 25020276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and biochemical presentation of polycystic ovary syndrome in women between the ages of 20 and 40.
    Liang SJ; Hsu CS; Tzeng CR; Chen CH; Hsu MI
    Hum Reprod; 2011 Dec; 26(12):3443-9. PubMed ID: 21926412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.